Lactobacilli and vaginal host defense: Activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-κB

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 653-660

  Klebanoff, Seymour J ^a   Watts, D Heather ^a   Mehlin, Christopher ^a   Headley, Catherine M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VANADIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; LACTOBACILLUS; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN INDUCTION; VAGINA DISCHARGE;

CATALASE; CELL LINE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; INTERLEUKIN-1; JURKAT CELLS; KINETICS; LACTOBACILLUS; MACROPHAGES; MONOCYTES; NF-KAPPA B; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VAGINA; VANADATES; VIRUS ACTIVATION;

EID: 0033376832     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314644     Document Type: Article

References (32)

1. 1. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990; 12:856-72.
2. 2. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989; 27:251-6.
3. 3. Klebanoff SJ, Clark RA. The neutrophil: function and clinical disorders. Amsterdam: North Holland, 1978.
4. 4. Klebanoff SJ, Smith DC. Peroxidase-mediated antimicrobial activity of rat uterine fluid. Gynecol Invest 1970; 1:21-30.
5. 5. Hamon CB, Klebanoff SJ. A peroxidase-mediated Streptococcus mitis dependent antimicrobial system in saliva. J Exp Med 1973; 137:438-50.
6. 2-generating lactobacilli. J Infect Dis 1991; 164:94-100.
7. 2-generating bacteria: requirement for peroxidase and a halide. J Infect Dis 1974; 129:345-8.
8. 8. Klebanoff SJ, Coombs RW. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 1991; 174:289-92.
9. 2 for the uterine fluid mediated sperm-inhibitory system. Biol Reprod 1970; 3:236-42.
10. 2-halide system: cytotoxic effect on mammalian tumor cells. Blood 1975; 45:161-70.
11. 11. Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. 2nd ed. New York: Raven Press, 1992:541-88.
12. 12. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. The relationship of hydrogen peroxide producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 1992; 79:369-73.
13. 13. Legrand-Poels S, Varia D, Pincemail J, Van de Vorst A, Piette J. Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retroviruses 1990; 6;1389-97.
14. 14. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10:2247-58.
15. 2-vanadate. Free Radic Biol Med 1996; 20:813-20.
16. 16. Kadota S, Fantus IG, Deragon G, Guyda HJ, Hersh B, Posner BI. Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 1987; 147:259-66.
17. 2. Mol Cell Biochem 1993; 129:9-29.
18. 18. Klebanoff SJ, Kazazi F, Van Voorhis WC, Schlechte KG. Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product. Proc Natl Acad Sci USA 1994; 91: 10615-9.
19. 19. Klebanoff SJ, Mehlin C, Headley CM. Activation of the HIV-1 long terminal repeat and viral replication by dimethylsulfoxide and related solvents. AIDS Res Hum Retroviruses 1997; 13:1221-7.
20. 20. Westphal O, Jann K. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965; 5:83-91.
21. 21. Fischer W, Koch HU, Haas R. Improved preparation of lipoteichoic acids. Eur J Biochem 1983; 133:523-30.
22. 22. Henderson B, Wilson M. Modulins: a new class of cytokine-inducing, pro-inflammatory bacterial virulence factor. Inflamm Res 1995; 44:187-97.
23. 23. Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996; 60:316-41.
24. 24. Holdman LV, Cato EP, Moore WEC. Anaerobe laboratory manual. 4th ed. Blacksburg, Virginia: Virginia Polytechnic Institute Anaerobe Laboratory, 1977.
25. 2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest 1975; 55:945-55.
26. 26. Neill MA, Henderson WR, Klebanoff SJ. Oxidative degradation of leukotriene C4 by human monocytes and monocyte-derived macrophages. J Exp Med 1985; 162:1634-44.
27. 27. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
28. 28. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11:1475-89.
29. 29. Brophy VH, Sibley CH. Expression of CD14 corrects the slow response to lipopolysaccharide in the 1B8 mutant of the B cell lymphoma 70Z/3. Immunogenetics 1998; 47:196-205.
30. 30. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12:141-79.
31. 31. Siebenlist U, Franzoso G, Brown K. Structure, regulation, and function of NF-κB. Annu Rev Cell Biol 1994; 10:405-55.
32. 32. Spear GT, Al-Harthi L, Sha B, et al. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS 1997; 11:1319-26.